SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-09-03

AUTHORS

Bo Gun Jang, Hye Sung Kim, Jeong Mo Bae, Woo Ho Kim, Heung Up Kim, Gyeong Hoon Kang

ABSTRACT

We aimed to investigate the expression profile of SPARC-related modular calcium-binding protein 2 (SMOC2) during colorectal cancer (CRC) progression and assess its prognostic impact in CRC patients. In our study, we showed that SMOC2 transcript level was higher in CRC samples than in normal mucosa (P = 0.017); this level was not associated with candidate cancer stem cell markers (CD44, CD166, CD133, and CD24) or intestinal stem cell markers (LGR5, ASCL2, and EPHB2) except for OLFM4 (P = 0.04). Immunohistochemical analysis showed that SMOC2-positive cells were confined to the crypt bases in the normal intestinal mucosa, hyperplastic polyps, and sessile serrated adenomas, whereas traditional serrated adenomas and conventional adenomas exhibited focal or diffuse distribution patterns. In total, 28% of 591 CRCs were positive for SMOC2, but SMOC2 positivity had negative correlations with lymphatic invasion (P = 0.002), venous invasion (P = 0.002), and tumor stage (P < 0.001). However, a positive association with nuclear β-catenin expression was seen. Furthermore, while upregulated SMOC2 expression was maintained during the adenoma-carcinoma transition, it decreased in cancer cells at the invasive front but did not decline further during lymph node metastasis. SMOC2 positivity showed no correlations with molecular abnormalities, including microsatellite instability, CpG island methylator phenotype, and mutations of KRAS and BRAF. In addition, we showed comprehensively that SMOC2 positivity is an independent prognostic marker for better clinical outcomes in a large cohort of CRC patients (P = 0.006). In vitro studies also demonstrated that induced SMOC2 expression in DLD1 cells exerts a suppressive role in tumor growth as well as in migration, colony, and sphere formation abilities. Taken together, our results suggest SMOC2 as a candidate tumor suppressor in CRC progression. More... »

PAGES

14591

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-020-71643-1

DOI

http://dx.doi.org/10.1038/s41598-020-71643-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1130538667

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32884102


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestinal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplastic Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University School of Medicine, Jeju, Korea", 
          "id": "http://www.grid.ac/institutes/grid.411277.6", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine, Jeju, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jang", 
        "givenName": "Bo Gun", 
        "id": "sg:person.0640426775.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640426775.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Jeju National University School of Medicine, Jeju, Korea", 
          "id": "http://www.grid.ac/institutes/grid.411277.6", 
          "name": [
            "Department of Pathology, Jeju National University School of Medicine, Jeju, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Hye Sung", 
        "id": "sg:person.0771453563.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771453563.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799 Korea", 
            "Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bae", 
        "givenName": "Jeong Mo", 
        "id": "sg:person.01161165725.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161165725.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799 Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799 Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Woo Ho", 
        "id": "sg:person.016630576674.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016630576674.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Jeju National University School of Medicine, Aran 13gil 15, Jeju, 690-767 Korea", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Jeju National University School of Medicine, Aran 13gil 15, Jeju, 690-767 Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Heung Up", 
        "id": "sg:person.01215500473.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215500473.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799 Korea", 
            "Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Gyeong Hoon", 
        "id": "sg:person.014551703117.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014551703117.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/onc.2015.127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016735278", 
          "https://doi.org/10.1038/onc.2015.127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2013.160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031039048", 
          "https://doi.org/10.1038/modpathol.2013.160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00428-011-1080-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012883838", 
          "https://doi.org/10.1007/s00428-011-1080-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-013-9908-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019492954", 
          "https://doi.org/10.1007/s12020-013-9908-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-017-06900-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090836401", 
          "https://doi.org/10.1038/s41598-017-06900-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-09-03", 
    "datePublishedReg": "2020-09-03", 
    "description": "We aimed to investigate the expression profile of SPARC-related modular calcium-binding protein 2 (SMOC2) during colorectal cancer (CRC) progression and assess its prognostic impact in CRC patients. In our study, we showed that SMOC2 transcript level was higher in CRC samples than in normal mucosa (P\u2009=\u20090.017); this level was not associated with candidate cancer stem cell markers (CD44, CD166, CD133, and CD24) or intestinal stem cell markers (LGR5, ASCL2, and EPHB2) except for OLFM4 (P\u2009=\u20090.04). Immunohistochemical analysis showed that SMOC2-positive cells were confined to the crypt bases in the normal intestinal mucosa, hyperplastic polyps, and sessile serrated adenomas, whereas traditional serrated adenomas and conventional adenomas exhibited focal or diffuse distribution patterns. In total, 28% of 591 CRCs were positive for SMOC2, but SMOC2 positivity had negative correlations with lymphatic invasion (P\u2009=\u20090.002), venous invasion (P\u2009=\u20090.002), and tumor stage (P\u2009<\u20090.001). However, a positive association with nuclear \u03b2-catenin expression was seen. Furthermore, while upregulated SMOC2 expression was maintained during the adenoma-carcinoma transition, it decreased in cancer cells at the invasive front but did not decline further during lymph node metastasis. SMOC2 positivity showed no correlations with molecular abnormalities, including microsatellite instability, CpG island methylator phenotype, and mutations of KRAS and BRAF. In addition, we showed comprehensively that SMOC2 positivity is an independent prognostic marker for better clinical outcomes in a large cohort of CRC patients (P\u2009=\u20090.006). In vitro studies also demonstrated that induced SMOC2 expression in DLD1 cells exerts a suppressive role in tumor growth as well as in migration, colony, and sphere formation abilities. Taken together, our results suggest SMOC2 as a candidate tumor suppressor in CRC progression.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-020-71643-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "independent prognostic marker", 
      "intestinal stem cell markers", 
      "stem cell markers", 
      "cell markers", 
      "CRC patients", 
      "prognostic marker", 
      "serrated adenomas", 
      "modular calcium-binding protein 2", 
      "cancer stem cell markers", 
      "lymph node metastasis", 
      "better clinical outcomes", 
      "colorectal cancer progression", 
      "normal intestinal mucosa", 
      "mutations of KRAS", 
      "candidate cancer stem cell markers", 
      "traditional serrated adenomas", 
      "SMOC2 expression", 
      "sessile serrated adenomas", 
      "adenoma-carcinoma transition", 
      "sphere formation ability", 
      "CpG island methylator phenotype", 
      "diffuse distribution pattern", 
      "prognostic impact", 
      "node metastasis", 
      "venous invasion", 
      "clinical outcomes", 
      "CRC progression", 
      "lymphatic invasion", 
      "tumor stage", 
      "colorectal cancer", 
      "CRC samples", 
      "normal mucosa", 
      "hyperplastic polyps", 
      "large cohort", 
      "intestinal mucosa", 
      "conventional adenomas", 
      "immunohistochemical analysis", 
      "better survival", 
      "invasive front", 
      "crypt bases", 
      "tumor growth", 
      "candidate tumor suppressor", 
      "suppressive role", 
      "molecular abnormalities", 
      "microsatellite instability", 
      "catenin expression", 
      "cancer progression", 
      "adenomas", 
      "cancer cells", 
      "methylator phenotype", 
      "DLD1 cells", 
      "positivity", 
      "patients", 
      "positive association", 
      "protein 2", 
      "mucosa", 
      "markers", 
      "SMOC2", 
      "tumor suppressor", 
      "progression", 
      "negative correlation", 
      "expression profiles", 
      "invasion", 
      "cells", 
      "formation ability", 
      "expression", 
      "metastasis", 
      "cohort", 
      "KRAS", 
      "cancer", 
      "abnormalities", 
      "BRAF", 
      "polyps", 
      "OLFM4", 
      "CRC", 
      "transcript levels", 
      "survival", 
      "outcomes", 
      "levels", 
      "total", 
      "study", 
      "association", 
      "correlation", 
      "SPARC", 
      "phenotype", 
      "suppressor", 
      "mutations", 
      "distribution patterns", 
      "role", 
      "profile", 
      "migration", 
      "stage", 
      "patterns", 
      "ability", 
      "samples", 
      "addition", 
      "impact", 
      "analysis", 
      "colonies", 
      "results", 
      "growth", 
      "basis", 
      "instability", 
      "transition", 
      "front", 
      "calcium-binding protein 2", 
      "SMOC2 transcript level", 
      "SMOC2-positive cells", 
      "SMOC2 positivity", 
      "upregulated SMOC2 expression", 
      "island methylator phenotype"
    ], 
    "name": "SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers", 
    "pagination": "14591", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1130538667"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-020-71643-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32884102"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-020-71643-1", 
      "https://app.dimensions.ai/details/publication/pub.1130538667"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_835.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-020-71643-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-71643-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-71643-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-71643-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-020-71643-1'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      22 PREDICATES      156 URIs      143 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-020-71643-1 schema:about N098fe6ed4d0c4f05813f8d3f23459dd7
2 N0aff123aae61445fb5f6208d1c129daa
3 N13836bdfc47d439ba9c1010afc8dc827
4 N2b01aaf16f5a422dadb7b202ef1c2f00
5 N2cdb0e57815b46f0be884165013f7ba0
6 N3a51fa7751204eeca4d0aa875883f887
7 N3e088d7ca3324c99829d1f1a5e2908c5
8 N5c343d7365e848f2b318b96124be59d4
9 N7cbb0e4f56ef4510bb4304bfb7352c43
10 N8734ecb24b164311a3eeb88e4b515c41
11 N9339f857e89e4cf299e7a0c26e167267
12 Nb1bb307805734f599616fa1d42896d7f
13 Ncb387b22d56d402ba5bf92568f0afac5
14 Ne922a908387146cab50f69a5797306d2
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Nd0553237239549b09b4c741cb70a2d4a
18 schema:citation sg:pub.10.1007/s00428-011-1080-3
19 sg:pub.10.1007/s12020-013-9908-z
20 sg:pub.10.1038/modpathol.2013.160
21 sg:pub.10.1038/onc.2015.127
22 sg:pub.10.1038/s41598-017-06900-x
23 schema:datePublished 2020-09-03
24 schema:datePublishedReg 2020-09-03
25 schema:description We aimed to investigate the expression profile of SPARC-related modular calcium-binding protein 2 (SMOC2) during colorectal cancer (CRC) progression and assess its prognostic impact in CRC patients. In our study, we showed that SMOC2 transcript level was higher in CRC samples than in normal mucosa (P = 0.017); this level was not associated with candidate cancer stem cell markers (CD44, CD166, CD133, and CD24) or intestinal stem cell markers (LGR5, ASCL2, and EPHB2) except for OLFM4 (P = 0.04). Immunohistochemical analysis showed that SMOC2-positive cells were confined to the crypt bases in the normal intestinal mucosa, hyperplastic polyps, and sessile serrated adenomas, whereas traditional serrated adenomas and conventional adenomas exhibited focal or diffuse distribution patterns. In total, 28% of 591 CRCs were positive for SMOC2, but SMOC2 positivity had negative correlations with lymphatic invasion (P = 0.002), venous invasion (P = 0.002), and tumor stage (P < 0.001). However, a positive association with nuclear β-catenin expression was seen. Furthermore, while upregulated SMOC2 expression was maintained during the adenoma-carcinoma transition, it decreased in cancer cells at the invasive front but did not decline further during lymph node metastasis. SMOC2 positivity showed no correlations with molecular abnormalities, including microsatellite instability, CpG island methylator phenotype, and mutations of KRAS and BRAF. In addition, we showed comprehensively that SMOC2 positivity is an independent prognostic marker for better clinical outcomes in a large cohort of CRC patients (P = 0.006). In vitro studies also demonstrated that induced SMOC2 expression in DLD1 cells exerts a suppressive role in tumor growth as well as in migration, colony, and sphere formation abilities. Taken together, our results suggest SMOC2 as a candidate tumor suppressor in CRC progression.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf Nd68a1d74cc034ceb85010844238df3e7
30 Nf8482bc1cabf4be193fe1523d4ac9e76
31 sg:journal.1045337
32 schema:keywords BRAF
33 CRC
34 CRC patients
35 CRC progression
36 CRC samples
37 CpG island methylator phenotype
38 DLD1 cells
39 KRAS
40 OLFM4
41 SMOC2
42 SMOC2 expression
43 SMOC2 positivity
44 SMOC2 transcript level
45 SMOC2-positive cells
46 SPARC
47 ability
48 abnormalities
49 addition
50 adenoma-carcinoma transition
51 adenomas
52 analysis
53 association
54 basis
55 better clinical outcomes
56 better survival
57 calcium-binding protein 2
58 cancer
59 cancer cells
60 cancer progression
61 cancer stem cell markers
62 candidate cancer stem cell markers
63 candidate tumor suppressor
64 catenin expression
65 cell markers
66 cells
67 clinical outcomes
68 cohort
69 colonies
70 colorectal cancer
71 colorectal cancer progression
72 conventional adenomas
73 correlation
74 crypt bases
75 diffuse distribution pattern
76 distribution patterns
77 expression
78 expression profiles
79 formation ability
80 front
81 growth
82 hyperplastic polyps
83 immunohistochemical analysis
84 impact
85 independent prognostic marker
86 instability
87 intestinal mucosa
88 intestinal stem cell markers
89 invasion
90 invasive front
91 island methylator phenotype
92 large cohort
93 levels
94 lymph node metastasis
95 lymphatic invasion
96 markers
97 metastasis
98 methylator phenotype
99 microsatellite instability
100 migration
101 modular calcium-binding protein 2
102 molecular abnormalities
103 mucosa
104 mutations
105 mutations of KRAS
106 negative correlation
107 node metastasis
108 normal intestinal mucosa
109 normal mucosa
110 outcomes
111 patients
112 patterns
113 phenotype
114 polyps
115 positive association
116 positivity
117 profile
118 prognostic impact
119 prognostic marker
120 progression
121 protein 2
122 results
123 role
124 samples
125 serrated adenomas
126 sessile serrated adenomas
127 sphere formation ability
128 stage
129 stem cell markers
130 study
131 suppressive role
132 suppressor
133 survival
134 total
135 traditional serrated adenomas
136 transcript levels
137 transition
138 tumor growth
139 tumor stage
140 tumor suppressor
141 upregulated SMOC2 expression
142 venous invasion
143 schema:name SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers
144 schema:pagination 14591
145 schema:productId N5e3e0811c1bd4e5e8a2f4cad4d6eb19b
146 N5ee65bbf7df5492ca57e45c29cb8ec37
147 Nf0ae66741bd64217ab3e0b4e20381340
148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130538667
149 https://doi.org/10.1038/s41598-020-71643-1
150 schema:sdDatePublished 2022-01-01T18:54
151 schema:sdLicense https://scigraph.springernature.com/explorer/license/
152 schema:sdPublisher N02c69e5eadf942de83163449b7dd677c
153 schema:url https://doi.org/10.1038/s41598-020-71643-1
154 sgo:license sg:explorer/license/
155 sgo:sdDataset articles
156 rdf:type schema:ScholarlyArticle
157 N02c69e5eadf942de83163449b7dd677c schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 N098fe6ed4d0c4f05813f8d3f23459dd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Gene Expression Regulation, Neoplastic
161 rdf:type schema:DefinedTerm
162 N0aff123aae61445fb5f6208d1c129daa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Survival Rate
164 rdf:type schema:DefinedTerm
165 N13836bdfc47d439ba9c1010afc8dc827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Cell Proliferation
167 rdf:type schema:DefinedTerm
168 N29a0223d3b7b49c1a727e62e5a42c362 rdf:first sg:person.01215500473.07
169 rdf:rest Ne07ce99e6d324aeb905ad6c0afc871a5
170 N2b01aaf16f5a422dadb7b202ef1c2f00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Calcium-Binding Proteins
172 rdf:type schema:DefinedTerm
173 N2cdb0e57815b46f0be884165013f7ba0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Colorectal Neoplasms
175 rdf:type schema:DefinedTerm
176 N3a51fa7751204eeca4d0aa875883f887 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Phenotype
178 rdf:type schema:DefinedTerm
179 N3e088d7ca3324c99829d1f1a5e2908c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Neoplastic Stem Cells
181 rdf:type schema:DefinedTerm
182 N4a952337b79549da86bcff75726554e1 rdf:first sg:person.0771453563.33
183 rdf:rest N655a74e8e58f41d0b73b5a8a07a9c759
184 N5c343d7365e848f2b318b96124be59d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Humans
186 rdf:type schema:DefinedTerm
187 N5e3e0811c1bd4e5e8a2f4cad4d6eb19b schema:name dimensions_id
188 schema:value pub.1130538667
189 rdf:type schema:PropertyValue
190 N5ee65bbf7df5492ca57e45c29cb8ec37 schema:name doi
191 schema:value 10.1038/s41598-020-71643-1
192 rdf:type schema:PropertyValue
193 N655a74e8e58f41d0b73b5a8a07a9c759 rdf:first sg:person.01161165725.74
194 rdf:rest N715ed78585724b6f9c3b610fc9828bb1
195 N715ed78585724b6f9c3b610fc9828bb1 rdf:first sg:person.016630576674.47
196 rdf:rest N29a0223d3b7b49c1a727e62e5a42c362
197 N7cbb0e4f56ef4510bb4304bfb7352c43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Mutation
199 rdf:type schema:DefinedTerm
200 N8734ecb24b164311a3eeb88e4b515c41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Tumor Cells, Cultured
202 rdf:type schema:DefinedTerm
203 N9339f857e89e4cf299e7a0c26e167267 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Biomarkers, Tumor
205 rdf:type schema:DefinedTerm
206 Nb1bb307805734f599616fa1d42896d7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Apoptosis
208 rdf:type schema:DefinedTerm
209 Ncb387b22d56d402ba5bf92568f0afac5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Intestinal Neoplasms
211 rdf:type schema:DefinedTerm
212 Nd0553237239549b09b4c741cb70a2d4a rdf:first sg:person.0640426775.09
213 rdf:rest N4a952337b79549da86bcff75726554e1
214 Nd68a1d74cc034ceb85010844238df3e7 schema:volumeNumber 10
215 rdf:type schema:PublicationVolume
216 Ne07ce99e6d324aeb905ad6c0afc871a5 rdf:first sg:person.014551703117.31
217 rdf:rest rdf:nil
218 Ne922a908387146cab50f69a5797306d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
219 schema:name Prognosis
220 rdf:type schema:DefinedTerm
221 Nf0ae66741bd64217ab3e0b4e20381340 schema:name pubmed_id
222 schema:value 32884102
223 rdf:type schema:PropertyValue
224 Nf8482bc1cabf4be193fe1523d4ac9e76 schema:issueNumber 1
225 rdf:type schema:PublicationIssue
226 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
227 schema:name Medical and Health Sciences
228 rdf:type schema:DefinedTerm
229 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
230 schema:name Oncology and Carcinogenesis
231 rdf:type schema:DefinedTerm
232 sg:journal.1045337 schema:issn 2045-2322
233 schema:name Scientific Reports
234 schema:publisher Springer Nature
235 rdf:type schema:Periodical
236 sg:person.01161165725.74 schema:affiliation grid-institutes:grid.31501.36
237 schema:familyName Bae
238 schema:givenName Jeong Mo
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161165725.74
240 rdf:type schema:Person
241 sg:person.01215500473.07 schema:affiliation grid-institutes:None
242 schema:familyName Kim
243 schema:givenName Heung Up
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215500473.07
245 rdf:type schema:Person
246 sg:person.014551703117.31 schema:affiliation grid-institutes:grid.31501.36
247 schema:familyName Kang
248 schema:givenName Gyeong Hoon
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014551703117.31
250 rdf:type schema:Person
251 sg:person.016630576674.47 schema:affiliation grid-institutes:grid.31501.36
252 schema:familyName Kim
253 schema:givenName Woo Ho
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016630576674.47
255 rdf:type schema:Person
256 sg:person.0640426775.09 schema:affiliation grid-institutes:grid.411277.6
257 schema:familyName Jang
258 schema:givenName Bo Gun
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640426775.09
260 rdf:type schema:Person
261 sg:person.0771453563.33 schema:affiliation grid-institutes:grid.411277.6
262 schema:familyName Kim
263 schema:givenName Hye Sung
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771453563.33
265 rdf:type schema:Person
266 sg:pub.10.1007/s00428-011-1080-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012883838
267 https://doi.org/10.1007/s00428-011-1080-3
268 rdf:type schema:CreativeWork
269 sg:pub.10.1007/s12020-013-9908-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1019492954
270 https://doi.org/10.1007/s12020-013-9908-z
271 rdf:type schema:CreativeWork
272 sg:pub.10.1038/modpathol.2013.160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031039048
273 https://doi.org/10.1038/modpathol.2013.160
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/onc.2015.127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016735278
276 https://doi.org/10.1038/onc.2015.127
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/s41598-017-06900-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1090836401
279 https://doi.org/10.1038/s41598-017-06900-x
280 rdf:type schema:CreativeWork
281 grid-institutes:None schema:alternateName Department of Internal Medicine, Jeju National University School of Medicine, Aran 13gil 15, Jeju, 690-767 Korea
282 schema:name Department of Internal Medicine, Jeju National University School of Medicine, Aran 13gil 15, Jeju, 690-767 Korea
283 rdf:type schema:Organization
284 grid-institutes:grid.31501.36 schema:alternateName Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799 Korea
285 Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
286 schema:name Department of Pathology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799 Korea
287 Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
288 rdf:type schema:Organization
289 grid-institutes:grid.411277.6 schema:alternateName Department of Pathology, Jeju National University School of Medicine, Jeju, Korea
290 schema:name Department of Pathology, Jeju National University School of Medicine, Jeju, Korea
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...